AzTrials
AzTrials

Tinnitus, SubjectiveNCT02774122

Cochleural Alternating Acoustic Beam Therapy (CAABT) Versus Masking Intervention for Tinnitus

A study testing CAABT and masking therapy in people with Tinnitus, Subjective, run by Beijing Friendship Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is to compare the effectiveness of CAABT and masking therapy in the management of subjective tinnitus in adults.Half of participants will receive CAABT, while the other half will receive masking therapy. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Tinnitus, Subjective
What is being tested?
CAABT and masking therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
Apr 2016to Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral tinnitus
  • Ages between 18-80 years
  • Tinnitus undergone for more than 6 months
  • Hearing loss of the tinnitus ear not affect communication
  • The main tinnitus frequency is less than 8 KHz
  • Primary tinnitus

Who cannot join

  • Secondary tinnitus
  • Hyperacusis
  • Patients were accepting any therapy about tinnitus
  • Those who have serious mental illness
  • Patients who can't fit the audiological examination and tinnitus tests
  • Most of the hearing loss in the middle and severe hearing loss of the tinnitus ear
  • Any MRI contraindications

Trial locations and contacts

1 site in 1 country.

China1 site
  • Otorhinolaryngology Head and Neck Surgery department

    Beijing, Beijing Municipality, 100031

Other trials in China

About this study

Official title: Cochleural Alternating Acoustic Beam Therapy Versus Masking Intervention for Tinnitus: A Randomised Controlled Trial

This study is to compare the effectiveness of CAABT and masking therapy in the management of subjective tinnitus in adults.Half of participants will receive CAABT, while the other half will receive masking therapy.

Read the detailed description

Masking intervention was a standard monophone tinnitus masking therapy. It was usually a narrow-band noise matched with tinnitus frequency (Tf).

CAABT was an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.

Being tested
CAABT, masking therapy
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CAABTDevice

    CAABT was an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.

  • masking therapyDevice

    Masking intervention was a standard monophone tinnitus masking therapy.

Study groups in NCT02774122
Study groupRoleWhat they receive
masking therapyActive comparatorMasking intervention was a standard monophone tinnitus masking therapy.
Receives: Device: masking therapy
CAABTExperimentalCAABT was an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.
Receives: Device: CAABT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Tinnitus Subjective Measures at 12 weeks: pure tone audiometry

    Measured: baseline and 12 weeks

  2. Change from Baseline in Tinnitus Subjective Measures at 12 weeks: tinnitus loudness

    Measured: baseline and 12 weeks

  3. Change from Baseline in Tinnitus Subjective Measures at 12 weeks: minimize masking level

    Measured: baseline and 12 weeks

  4. Change from Baseline in Tinnitus Subjective Measures at 12 weeks: the Chinese version of Tinnitus Handicap Inventory scale

    Measured: baseline and 12 weeks

  5. Change from Baseline in Tinnitus Subjective Measures at 12 weeks: the Visual Analog Scale

    Measured: baseline and 12 weeks

Secondary outcomes (1)
  1. Change from Baseline in Tinnitus Objective Measure at 12 weeks: functional magnetic resonance imaging (fMRI)

    Measured: baseline and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionAug 2018 (estimated)
  4. Study completionOct 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02774122
Sponsor's protocol ID
961619
Status last verified
Jan 2018
First submitted
8 May 2016
Last updated
23 Jan 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: individual participant data(IPD) for all subjective and objective outcome measures will be made available within 6 months of study completion

Publications

  • Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, Anteunis LJ, van Breukelen GJ, Vlaeyen JW. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9. doi: 10.1016/S0140-6736(12)60469-3.

    PubMed 22633033
  • Liu C, Zhang J, Qi Z, Yue W, Yuan Y, Jiang T, Zhang S, Zhang S. Therapy effect of cochleural alternating acoustic beam therapy versus traditional sound therapy for managing chronic idiopathic tinnitus patients. Sci Rep. 2024 Mar 11;14(1):5900. doi: 10.1038/s41598-024-55866-0.

    PubMed 38467716
  • Wei X, Lv H, Wang Z, Liu C, Ren P, Zhang P, Chen Q, Liu Y, Zhao P, Gong S, Yang Z, Wang Z. Neuroanatomical Alterations in Patients With Tinnitus Before and After Sound Therapy: A Voxel-Based Morphometry Study. Front Neurosci. 2020 Sep 8;14:911. doi: 10.3389/fnins.2020.00911. eCollection 2020.

    PubMed 33013302
  • Liu C, Lv H, Jiang T, Xie J, He L, Wang G, Liu J, Wang Z, Gong S. The Cochleural Alternating Acoustic Beam Therapy (CAABT): A pre-clinical trial. Am J Otolaryngol. 2018 Jul-Aug;39(4):401-409. doi: 10.1016/j.amjoto.2018.04.002. Epub 2018 Apr 3.

    PubMed 29655489

Questions about this trial

What is this clinical trial studying?

A study testing CAABT and masking therapy in people with Tinnitus, Subjective, run by Beijing Friendship Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Tinnitus Subjective Measures at 12 weeks: pure tone audiometry (time frame: baseline and 12 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02774122, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in